Castleview Partners’s Organigram Holdings OGI Stock Holding History

Castleview Partners’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-250	Closed	-$385	–	793
2024 Q2	$385	Hold	250	–	–	﹤0.01%	861
2024 Q1	$538	Hold	250	–	–	﹤0.01%	836
2023 Q4	$328	Hold	250	–	–	﹤0.01%	821
2023 Q3	$330	Hold	250	–	–	﹤0.01%	651
2023 Q2	$390	Hold	250	–	–	﹤0.01%	667
2023 Q1	$640	Hold	250	–	–	﹤0.01%	638
2022 Q4	$800	Hold	250	–	–	﹤0.01%	568
2022 Q3	$1K	Buy	250 +220	+733%	+$921	﹤0.01%	585
2022 Q2	$4.08K	Sell	30 -220	-88%	-$1.12K	﹤0.01%	567
2022 Q1	$1K	Sell	250 -188	-43%	-$1.16K	﹤0.01%	680
2021 Q4	$1K	Buy	+438	New	+$3.72K	0.01%	396
2021 Q2	$3K	Buy	+250	New	+$2.85K	﹤0.01%	839

Other funds holding OGI

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Castleview Partners's OGI Position: Q3 2024 in Review

Castleview Partners sold out of Organigram Holdings (OGI) in Q3 2024, closing a stake of 250 shares — an estimated $385 sold.

Castleview Partners first reported a position in OGI in Q2 2021 and held it in 12 quarters. The position peaked at $4.08K in Q2 2022. 71 funds tracked by Wall St. Rank hold OGI as of Q3 2024.

Castleview Partners reported no remaining Organigram Holdings position as of Q3 2024 after selling out during the quarter.
Castleview Partners sold 250 Organigram Holdings shares in Q3 2024, an estimated $385.
Castleview Partners first reported a position in Organigram Holdings in Q2 2021 and held it in 12 quarters.
Castleview Partners's Organigram Holdings position peaked at $4.08K in Q2 2022.
71 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.